Skip to main content
OpenTrials
Completed

NCT Number: NCT00417456

The Development and Evaluation of an "E-Visit" Program for the Management of Acne

The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses:

1. That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne. 2. That providers and patients will be satisfied with this model. 3. That mean wait times for new and return visits will be reduced through the "E-Visit" model. 4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acne Vulgaris Acneiform Eruptions Sebaceous Gland Diseases Skin Diseases Skin and Connective Tissue Diseases

Age range

12 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brigham and Women's Hospital Department of Dermatology, Boston, Massachusetts, United States

Loading trial locations.

About this study

Across the United States, a geographically mal-distributed workforce of Dermatologists exists, a problem that is projected to worsen. Patient access to dermatologic care is threatened. The dermatology workforce shortage has resulted in long wait times for patients, especially new patient visits and acute care cases.

Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.

Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:

Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.

Group 2- The second group will have four (4) "e-visits" spaced six weeks apart.

At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 12 or older
  • Diagnosis of mild to severe facial acne
  • Access to a credit card
  • Access to an Internet connection and a computer
  • Ability to image self
  • MA Blue Cross/ Blue Shield Coverage

Exclusion criteria

  • Non-English speaking individuals
  • Patients taking Accutane for their acne
  • Impaired Physical ability to image self
  • Impaired Cognitive ability

Treatment and study plan

Evisit

Other

Asynchronous,remote care delivery via a secure web platform

Other names: RelayHealth platform

Office Visit

Other

Conventional office-based care

Primary outcomes

  1. Peer review of subject images using the Total Inflammatory Lesion Count at the end of active recruitment

    Time frame: 6 months

Secondary outcomes

  1. Subject satisfaction

    Time frame: 6 months

  2. Physician satisfaction

    Time frame: 6 months

  3. Timing of visits

    Time frame: ongoing

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Jan 1, 2007
Registry last updated
Mar 16, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.